A vast range of different active pharmaceutical components and medication formulations are present in the developing field of nanomedicine. Their creation gives nanomedicines special properties that enhance pharmacokinetics and pharmacodynamics. They are created utilizing manufacturing methods that are biotechnology or traditional. They are physically very dissimilar from conventional small-molecule medications. The multidisciplinary team of scientists working on their research and clinical use includes pharmacists, who play a significant role. As a result, their education should enable them to comprehend the challenges involved in the development and assessment of nanomedicines. Therefore, additional exposure to this rapidly growing class of treatments should be provided to trainees, postdoctoral researchers, and student pharmacists
